Clinical Trial Update: Prostate Adenocarcinoma TransCutaneous Hormones [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for TransCutaneous Hormones in prostate adenocarcinoma, with listed conditions including anemia, cardiovascular complications, h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cardiovascular Complications
• Hot Flashes
• Osteoporosis
• Prostate Cancer

Drugs mentioned

• TransCutaneous Hormones

Snippet

Sponsor: University College, London | Conditions: Anemia, Cardiovascular Complications | Phase 3 | Status: UNKNOWN